EXTRAMURAL AND DU FUNDING
Ongoing / Completed Projects (2018 onwards)
| S.No. | Name of the PI | Project title | Duration | Amount | Funding agency |
| 1. | Dr. Vijay K. Prajapati | Quantification and expression of anti-apoptotic and pro-apoptotic proteins of Leishmania parasites for developing novel therapeutics |
25th April 2024 to 24th April 2028 |
Rs. 2,20,41,907 | ICMR |
| 2. | Dr. Vijay K. Prajapati | Inhibiting glycosomal membrane biogenesis as a potential leishmaniasis treatment |
15th April 2024 to 14th April 2028 |
Rs. 97,22,744 | ICMR |
| 3. | Prof. Alo Nag | Understanding the tumor suppressive properties of Artemisinin in blocking the oncogenic activities of FoxM1 and HBx in hepatocellular carcinoma |
October 2023 to October 2026 |
Rs. 25,00,000 | CSIR |
| 4. | Prof. Alo Nag | Understanding the Mechanism of HBx mediated Manipulation of FoxM1 in Hepatocellular Carcinoma |
March 2021 to |
Rs.62.84 lacs | DST-SERB |
| 5. | Prof. Debi P. Sarkar |
Utilization of Sendai virus-derived proteoliposomes to deliver the UGT1A1 gene by editing with CRISPR/Cas9 in rat hepatocytes |
3 years |
~Rs.95 lacs | ICMR |
| 6. | Dr. Garima Khare | Targeting dormant Mycobacterium tuberculosis in Bone Marrow Mesenchymal Stem Cells by inhibiting ABCG2 efflux pumps | Nov 2019- Oct 2022 | Rs.47.63 lacs | SERB, DST |
| 7. | Prof. Suman Kundu | Understanding the structure of Leishmaniaamajor Phosphopantetheinyl Transferase (Lmj PPTase) and its interaction with cognate ACP | 23rd May 2019 to 22nd May 2020 | Rs.2,63,400 | UGC-DAE Consortium for Scientific Research |
| 8. | Prof. Suman Kundu | Development of Hemoglobin based artificial oxygen carrier: engineering recombinant and packaged hemoglobin | 13th June 2018 to 12th June 2021 | Rs.65,43,392 | DRDO (LSRB) |
| 9. | Prof. Suman Kundu | Understanding the structure of Leishmaniaamajor Phosphopantetheinyl Transferase (Lmj PPTase) and its interaction with cognate ACP | 1st April 2018 to 31st March 2019 | Rs.2,63,400 | UGC-DAE Consortium for Scientific Research |
| 10. | Prof. Alo Nag | Identification, Design and Characterization of peptides to disrupt hADA3-E6 interaction for HPV induced cervical cancer therapy. | 29th December 2017 to 28th December 2020 | Rs.64,33,400 | DBT |
| 11. | Dr. Garima Khare | Maintenance and Operation of the Biosafety Facility (level 3), for Tuberculosis research | 30.08.2018 - 29.08.2021 | Rs.10315132 | DBT |
| 12. | Dr. Garima Khare | Drug discovery approaches for the effective control of tuberculosis – target based virtual screening and whole cell screening of medicinal plants | 19.09.2018 - 18.09.2021 | Rs. 4110400 | DBT |
Evidences (1) (2) (3) (4) (5)
The department qualified for the FIST (level I) support by DST (2003-2008).
The Department has been endowed with the Special Assistance Programme grant by UGC (2009-2014, DRS Phase I and 2016-2021, DRS Phase II) to strengthen research/teaching with the focus on “Development of Molecular Strategies to Combat Various Human Diseases”.
SUMMARY OF EXTRAMURAL FUNDING FOR FACULTIES (2012-2017)
No. of Grants received : 16
Quantum of grants received : Rs. 80,505,2016
SUMMARY OF EXTRAMURAL FUNDING FOR THE DEPARTMENT
Quantum of grants received : Rs.14,96,4936 (UGC-SAP); Rs.56.92 lacs (DST-FIST)
Funding Evidences
Consultancy
List of Research Grants 2012-2017
National and International Collaborations Funded
